Papillary thyroid carcinoma in a 9-year-old girl with ataxia-telangiectasia

Pediatric Blood and Cancer

Volumn 50, Issue 5, 2008, Pages 1058-1060

  Brasseur, Benoit ^a   Beauloye, Véronique ^a   Chantrain, Christophe ^a   Daumerie, Chantai ^a   Vermylen, Christiane ^a   Waignein, Frédéric ^a   Brichard, Bénédicte ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Ataxia telangiectasia; Cancer predisposition; DNA damage; Thyroid carcinoma

Indexed keywords

ARTICLE; ATAXIA TELANGIECTASIA; ATM GENE; CANCER RISK; CARCINOGENESIS; CASE REPORT; FEMALE; GENE; GENE MUTATION; HUMAN; LYMPH NODE; PRIORITY JOURNAL; SCHOOL CHILD; THYROID PAPILLARY CARCINOMA;

ATAXIA TELANGIECTASIA; CARCINOMA, PAPILLARY; CELL CYCLE PROTEINS; CHILD; DNA-BINDING PROTEINS; FEMALE; HUMANS; MUTATION; PROTEIN-SERINE-THREONINE KINASES; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 41849150454     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21016     Document Type: Article

References (17)

1. Yang J, Yu ZP, Huang Y, et al. ATM and ATR: Sensing DNA damage. World J Gastroenterol 2004;10:155-160.
2. Kurz EU, Lees-Miller SP. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair 2004;3:889-900.
3. Olsen JH, Hahnemann JM, Borresen-Dale AL, et al. Cancer in patients with ataxia telangiectasia and in their relatives in the Nordic countries. J Natl Cancer Inst 2001;93:121-127.
4. Sandoval C, Schantz S, Posey D, et al. Parotid and thyroid gland cancers in patients with ataxia-telangiectasia. Ped Hematol Oncol 2001;18:485-490.
5. Taylor AMR, Metcalfe JA, Thick J, et al. Leukemia and lymphoma in ataxia telangiectasia. Blood 1996;87:423-438.
6. Geoffroy-Perez B, Janin N, Ossian K, et al. Cancer risk in heterozygotes for ataxia-telangiectasia. Int J Cancer 2001;93:288-293.
7. Halac I, Zimmerman D. Thyroid nodules and cancers in children. Endocrinol Metab Clin N Am 2005;34:725-744.
8. Ohta S, Katsura T, Shimada M, et al. Ataxia-telangiectasia with papillary carcinoma of the thyroid. Am J Pediatr Hematol Oncol 1986;8:255-257.
9. Narita T, Takagi K. Ataxia-telangiectasia with dysgerminoma of right ovary, papillary carcinoma of thyroid, and adenocarcinoma of pancreas. Cancer 1984;54:1113-1116.
10. Bay JO, Uhrhammer N, Hall J, et al. Fonctions de la protéine ATM et aspects phénotypiques de l'ataxie-télangiectasie. MÕdecine/ Sciences 1999;15:1086-1095.
11. Matsuo SE, Martins SE, Leoni SG, et al. Biological markers in thyroid tumors. Arq Bras Endocrinol Metabol 2004;48:114-120.
12. Goto A, Sakamoto A, Machinami R. An immunohistochemical analysis of cyclin D1, p53, and p21waf1/cip1 proteins in tumors originating from the follicular epithelium of the thyroid gland. Pathol Res Pract 2001;197:217-222.
13. Khoo MLC, Beasley NJP, Ezzat S, et al. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metabol 2002;87: 1814-1818.
14. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Eng J Med 1998;338:297-306.
15. Collini P, Massimino M, Leite SF, et al. Papillary carcinoma of childhood and adolescence: A 30-year experience at the Istituto Nazionale Tumori in Milan. Pediatr Blood Cancer 2006;46:300-306.
16. Zidan J, Karen D, Stein M, et al. Pure versus follicular variant of papillary thyroid carcinoma: Clinical features, prognostic factors, treatment, and survival. Cancer 2003;97:1181-1185.
17. Massimino M, Collini P, Leite SF, et al. Conservative surgical approach for thyroid and lymph-node involvement in papillary thyroid carcinoma of childhood and adolescence. Pediatr Blood Cancer 2006;46:307-313.